Medicine & Life Sciences
Infliximab
81%
Colitis
71%
MicroRNAs
58%
Prostate
58%
Inflammatory Bowel Diseases
57%
Case-Control Studies
55%
Stem Cells
51%
Neoplasms
44%
Antigens
44%
Adenoma
32%
Genes
28%
Colectomy
19%
Ulcerative Colitis
17%
Biological Products
17%
Crohn Disease
16%
Adenomatous Polyps
15%
Carcinoma
15%
Staining and Labeling
14%
Small Untranslated RNA
14%
Gastrointestinal Neoplasms
13%
Steroids
12%
Chemoprevention
12%
Colonoscopy
11%
Healthcare-Associated Pneumonia
11%
Anastomotic Leak
10%
Mortality
10%
Colorectal Neoplasms
9%
National Institutes of Health (U.S.)
9%
Wound Infection
8%
Survival Rate
8%
Cytomegalovirus
8%
Pulmonary Embolism
8%
Cyclosporine
8%
Patient Selection
7%
Biomarkers
7%
Gene Expression
6%
Morbidity
6%
DNA
6%
Tumor Necrosis Factor-alpha
6%
Maintenance
6%
Delivery of Health Care
5%
Databases
5%
Social Sciences
Cancer Prevention
100%
cancer
63%
morbidity
23%
mortality
19%
cause
13%
management
11%